<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00473902</url>
  </required_header>
  <id_info>
    <org_study_id>Older Adult Training Study</org_study_id>
    <nct_id>NCT00473902</nct_id>
  </id_info>
  <brief_title>Older Adult Training Study With Creatine and CLA</brief_title>
  <acronym>OTR</acronym>
  <official_title>Creatine Monohydrate and Conjugated Linoleic Acid Improve Strength and Body Composition Following Resistance Exercise in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We examined whether creatine monohydrate (CrM) and conjugated linoleic acid (CLA) could
      enhance strength gains and improve body composition (i.e., increase fat-free mass (FFM);
      decrease body fat) following resistance exercise training in older adults (&gt; 65 y). Our study
      hypothesized that administering CrM and CLA would yield greater strength and body composition
      benefits than the placebo group over the six months of resistance exercise
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Men (N=19) and women (N=20) completed six months of resistance exercise training with
      Creatine Monohydrate (5g/d) + Conjugated Linoleic Acid (6g/d) or placebo with randomized,
      double-blind, allocation.Outcomes included; strength and muscular endurance, functional
      tasks, body composition (DEXA scan), blood tests (lipids, liver function, CK, glucose,
      systemic inflammation markers (IL-6, C-reactive protein)), urinary markers of compliance
      (creatine/creatinine), oxidative stress (8-OH-2dG, 8-isoP) and bone resorption
      (Œù-telopeptides).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">September 2004</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>a. Muscle and bone mass b. Knee extension strength e. Creatine content f. Muscle oxidative capacity g. Aerobic power (oxygen consumption)</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>a. Functional capacity b. Strength with weight machines</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">39</enrollment>
  <condition>Sarcopenia</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Training</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Creatine Monohydrate, Conjugated Linoleic Acid</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy,

          -  Ambulatory,

          -  Recreationally active,

          -  Community dwelling

        Exclusion Criteria:

          -  Evidence of coronary heart disease;

          -  Congestive heart disease;

          -  Uncontrolled hypertension;

          -  Chronic obstructive pulmonary disease;

          -  Diabetes mellitus;

          -  Renal failure;

          -  Major orthopedic disability; and

          -  Smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark A Tarnopolsky, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McMaster University Medical Center</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2007</study_first_submitted>
  <study_first_submitted_qc>May 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2007</study_first_posted>
  <last_update_submitted>May 15, 2007</last_update_submitted>
  <last_update_submitted_qc>May 15, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

